The fifth annual Corporate Venture Capital Summit is hosting over 24 Corporate Investors that have volunteered to share their knowledge, perspectives, and standards for those in attendance.
The event is becoming quickly recognized as the premier location for startups to network directly with venture capitalists and Corporate Development Officers.
When:
Tuesday February 24, 2009
Where:
British Consulate
One Memorial Drive
Cambridge, MA 02142
Speakers include (but not limited to):
Patrick Chung Managing Director SK Telecom Ventures
Dave Schulte Principal Kaiser Permanente Ventures
Tara D. Butler, M.D. Investment Director Ascension Health Ventures
Early registration save attendees $200 off the at the door fee.
Register Here
Agenda:
(Source Youngstartup.com)
1:00 pm CONFERENCE REGISTRATION & NETWORKING
1:30 pm WELCOME REMARKS & KEYNOTE
Joe Benjamin
Founder & CEO
youngStartup Ventures
2:00 pm BEYOND THE MONEY
This session will explore the benefits of raising Corporate VC and how it yields important dividends that are “beyond the bottom line,” both for the investor and for the startup firm.
Panelists:
Rajeev Dadoo, Ph.D.
Principal
SR One
Mathew George, CFA
Vice President
TELUS Ventures
Julie Gerstenberger
Director, External Alliances
Kodak Ventures
Alan J. Koenning
Fund Manager
UPS Strategic Enterprise Fund
David Nanto
Director of Venture Development
NEC Corporation of America
Ira Nydick
Senior Technology Analyst
Panasonic Venture Group
Lauren Silverman, Ph.D.
Managing Director
Novartis BioVentures
2:50 pm BREAK
3:00 pm COMPANY PRESENTATIONS – ROUND I
3:40 pm
INVESTING IN OUTSIDE INNOVATION: WHAT ARE CORPORATE VCs LOOKING TO FUND AND UNDER WHAT CONDITIONS?
Just as all companies have different strategic goals and interests, so to their Corporate VC divisions have highly varied strategies and approaches. Still, all involve some balance or mix of strategic corporate goals and financial ROI. This session will explore why certain deals and ventures have been historically of interest to corporate VC’s and how this is playing out in the current market space.
Panelists:
Tara D. Butler, M.D.
Investment Director
Ascension Health Ventures
Dan Keoppel
Executive Director, Strategic Investments
Verizon Communications
Jeffrey B. Moore
Vice President
MP Healthcare Venture Management
Jim Peters
Partner
Geisinger Ventures
Jennifer Scholze
Partner
SAP Ventures
Tom Whiteaker
AVP
Hartford Ventures
Kuk Yi
Managing Partner
Best Buy Capital
4:30 pm BREAK
4:40 pm COMPANY PRESENTATIONS – ROUND II
5:10 pm BUILDING THE BRIDGE – CORPORATE & TRADITIONAL CAPITAL
While close to 20% of all venture-backed firms have corporate VC’s on board, it is unusual for a venture to be backed by corporate VC alone. When other investors are required corporate VC interests must be balanced with those of other investors, while at the same time ensuring that the venture moves forward and remains robust. This session will examine these different pieces to the Corporate Venture puzzle and how to best leverage the roles of all players involved.
Panelists:
Patrick Chung
Managing Director
SK Telecom Ventures
Andrew T. Jay
Managing Partner
Siemens Venture Capital
Stephen Knight, M.D.
Managing Partner
Fidelity BioSciences
Lucy Mcquilken
Director
Intel Capital
Jim Sanger
General Partner
ABS Ventures
Dave Schulte
Principal
Kaiser Permanente Ventures
Spencer Tall
Managing Director
Allegis Capital
6:00 pm CAPSTONE PRESENTATION & CLOSING REMARKS
6:15 pm COCKTAIL RECEPTION
8:00 pm SUMMIT ADJOURNS
